Benefits of Indefinite Anticoagulant Unclear After First VTE

THURSDAY, June 29, 2023 (HealthDay News) -- For patients with a first unprovoked venous thromboembolism (VTE), indefinite anticoagulation prevents some recurrent VTE events but induces additional major bleeding events, according to a study published online June 27 in the Annals of Internal Medicine.
Faizan Khan, Ph.D., from the University of Calgary in Canada, and colleagues estimated the benefit-harm tradeoffs of indefinite anticoagulation in patients with a first unprovoked VTE who completed three to six months of initial anticoagulant treatment.
The researchers found that in a hypothetical cohort of 1,000 patients aged 55 years, indefinite anticoagulation prevented 368 recurrent VTE events, including 14 fatal pulmonary emboli in the base-case analysis, but induced 114 major bleeding events, including 30 intracranial hemorrhages and 11 deaths from bleeding. The cost of indefinite anticoagulation was $16,014 (in Canadian dollars) more per person, and did not increase quality-adjusted life years. In the sensitivity analysis, during extended anticoagulation, the model results were most sensitive to the case-fatality rate of major bleeding and the annual risk for major bleeding.
"Continuing versus discontinuing anticoagulation indefinitely in all (that is, unselected) patients with a first unprovoked VTE has little chance of improving life expectancy but might provide a mortality benefit in certain subgroups," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Seafood in Pregnancy: To Eat or Not to Eat?
TUESDAY, Jan. 24, 2023 (HealthDay News) -- Pregnant women hear a lot of “Do...
Impact of Climate Change on Neurologic Health Reviewed
THURSDAY, Nov. 17, 2022 (HealthDay News) -- The impact of climate change on...
AHA News: Estudiante de medicina espera ser la doctora que sus padres necesitaban cuando ella era niña
MIÉRCOLES, 19 de abril de 2023 (American Heart Association News) -- Melissa...
UK Eases COVID Testing Rules for International Visitors
THURSDAY, Jan. 6, 2022 (HealthDay News) -- British Prime Minister Boris Johnson...